Drug Type Small molecule drug |
Synonyms BAB 104, BAB104 |
Target |
Action inhibitors |
Mechanism TEAD inhibitors(TEA domain transcription factors inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glioblastoma | Preclinical | South Korea | 28 Apr 2024 | |
| Mesothelioma, Malignant | Preclinical | South Korea | 28 Apr 2024 |





